Tech Company Financing Transactions
Allegria Therapeutics Funding Round
Allegria Therapeutics closed a $3.5 million Seed funding round on 5/6/2024. Backers included Forty51 Ventures.
Transaction Overview
Company Name
Announced On
5/6/2024
Transaction Type
Venture Equity
Amount
$3,500,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to progress a differentiated portfolio of proprietary therapeutic approaches around targets that selectively modulate mast cells to more effectively address patients' needs.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Aeschenvorstadt 48
Basel, 4051
Switzerland
Basel, 4051
Switzerland
Phone
Undisclosed
Website
Email Address
Overview
Allegria Therapeutics, a Basel, Switzerland-based company focused on advancing a pipeline of therapeutics for mast cell-mediated diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Maria van Dongen
Browse more venture capital transactions:
Prev: 5/6/2024: GoMining venture capital transaction
Next: 5/6/2024: OverT Bio venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs